Biodesix Total Current Assets 2020-2025 | BDSX
Biodesix total current assets from 2020 to 2025. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
| Biodesix Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $39 |
| 2023 | $40 |
| 2022 | $53 |
| 2021 | $44 |
| 2020 | $86 |
| 2019 | $13 |
| Biodesix Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $30 |
| 2024-12-31 | $39 |
| 2024-09-30 | $44 |
| 2024-06-30 | $58 |
| 2024-03-31 | $28 |
| 2023-12-31 | $40 |
| 2023-09-30 | $29 |
| 2023-06-30 | $25 |
| 2023-03-31 | $35 |
| 2022-12-31 | $53 |
| 2022-09-30 | $24 |
| 2022-06-30 | $35 |
| 2022-03-31 | $27 |
| 2021-12-31 | $44 |
| 2021-09-30 | $56 |
| 2021-06-30 | $68 |
| 2021-03-31 | $81 |
| 2020-12-31 | $86 |
| 2020-09-30 | $18 |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.061B | $0.071B |
| Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.222B | 26.93 |
| CVS Health (CVS) | United States | $74.320B | 9.24 |
| Elevance Health (ELV) | United States | $63.147B | 8.49 |
| Cencora (COR) | United States | $56.296B | 19.58 |
| DiDi Global (DIDIY) | China | $26.168B | 27.80 |
| Labcorp Holdings (LH) | United States | $22.406B | 17.68 |
| Natera (NTRA) | United States | $19.262B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| ICON (ICLR) | Ireland | $15.748B | 15.15 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.835B | 0.00 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.801B | 33.88 |
| Solventum (SOLV) | United States | $12.791B | 13.54 |
| Revvity (RVTY) | United States | $12.019B | 20.68 |
| Viatris (VTRS) | United States | $10.974B | 3.77 |
| Avantor (AVTR) | United States | $9.547B | 13.87 |
| Sonic Healthcare (SKHHY) | Australia | $9.287B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.698B | 17.05 |
| HealthEquity (HQY) | United States | $8.162B | 35.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
| BrightSpring Health Services (BTSG) | United States | $3.632B | 33.32 |
| Sotera Health (SHC) | United States | $3.437B | 19.53 |
| Surgery Partners (SGRY) | United States | $2.693B | 35.02 |
| Organon (OGN) | United States | $2.618B | 2.78 |
| Concentras Parent (CON) | United States | $2.517B | 14.55 |
| GeneDx Holdings (WGS) | United States | $2.324B | 89.50 |
| Alignment Healthcare (ALHC) | United States | $2.303B | 0.00 |
| Progyny (PGNY) | United States | $1.972B | 43.40 |
| GoodRx Holdings (GDRX) | United States | $1.775B | 35.50 |
| Premier (PINC) | United States | $1.747B | 13.26 |
| PACS (PACS) | United States | $1.742B | 0.00 |
| Ardent Health (ARDT) | United States | $1.543B | 6.58 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.248B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.067B | 8.12 |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.857B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.750B | 7.03 |
| CareDx (CDNA) | United States | $0.715B | 11.16 |
| Embecta (EMBC) | United States | $0.665B | 4.48 |
| Nutex Health (NUTX) | United States | $0.532B | 8.05 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| SBC Medicals (SBC) | United States | $0.505B | 0.00 |
| Omada Health (OMDA) | $0.486B | 0.00 | |
| LifeMD (LFMD) | United States | $0.485B | 0.00 |
| So-Young (SY) | China | $0.480B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.55 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.349B | 28.71 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.287B | 0.00 |
| Beauty Health (SKIN) | United States | $0.231B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.187B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.083B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |